Sunshine Lake Pharma Co (HKSE:06887) Research & Development: HK$713 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06887 Sunshine Lake Pharma Co Ltd HKSE:06887
15 GF Score
Price HK$38.50
! 2 Warning Signs
View Full Analysis

What is Sunshine Lake Pharma Co Research & Development?

Sunshine Lake Pharma Co HKSE:06887 +3.00% 15 Research & Development is HK$713 Mil as of Dec. 2025. GuruFocus rates HKSE:06887 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sunshine Lake Pharma Co's Research & Development for the six months ended in Dec. 2025 was HK$332 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$713 Mil.

Sunshine Lake Pharma Co  (HKSE:06887) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sunshine Lake Pharma Co Research & Development Related Terms

Sunshine Lake Pharma Co Research & Development Historical Data

* Premium members only.

The historical data trend for Sunshine Lake Pharma Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Lake Pharma Co Research & Development Chart

Sunshine Lake Pharma Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
884.04 905.01 947.72 716.62

Sunshine Lake Pharma Co Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 0.00 433.18 518.11 380.62 331.94
HKSE:06887
15GF Score
Sunshine Lake Pharma Co Ltd HKSE:06887
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Lake Pharma Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$713 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$713 Mil mean?
Sunshine Lake Pharma Co (HKSE:06887) has a Research & Development of HK$713 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Sunshine Lake Pharma Co and its competitors.
Is Sunshine Lake Pharma Co's Research & Development too high?
Sunshine Lake Pharma Co's current Research & Development is HK$713 Mil. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's Research & Development compare to ZTS?
Sunshine Lake Pharma Co's Research & Development of HK$713 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sunshine Lake Pharma Co and its competitors. Sunshine Lake Pharma Co's current Research & Development is HK$713 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current Research & Development of HK$713 Mil. The current Research & Development is HK$713 Mil. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current Research & Development is HK$713 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunshine Lake Pharma Co Business Description

Address No. 368 Zhen An Zhong Road, HEC Scientific Park, Chang’an County, Guangdong Province, Dongguan, CHN
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score

Get the complete analysis for HKSE:06887

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$38.50
Price